Allstate: Benefiting From Cost Improvements (Upgrade)

Allstate (NYSE: ALL ) is a stock that I covered last year with skepticism. Titled A Non-Grower Priced for Growth, I rated it a Sell. There were many things I didn't like about the business, which IMy articles are written with a mind to owning a stock for years, not trying to predict price movements in a few months. I don't do target prices; I do valuations.I first entered investing in 2020 as an individual value investor, keen to understand the fundamentals of businesses and buy their shares at attractive p ...